butyrate and glp 1 to combat obesity obesity‐associated metabolic disorders: Current status and future implications for therapeutic use - Deuren - 2022 - Obesity Reviews GLP-1 and the Gut: Natural

Last reviewed: June 23, 2026 Last updated: June 23, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations

It belongs to the class B family of G protein-coupled receptors, also known as secretin-like receptors

doi:10.1007/s12325-022-02153-x Yao H, Zhang A, Li D, et al

These trials include new intramuscular injections by Daewoong Pharmaceuticals of South Korea (36), and a nasal spray and inhalant as a spray-dried-lysozyme particulate of micronized-niclosamide (37), that has entered a 1,500 high-risk kidney patient study in the UK with Union Therapeutics in Denmark (38)